Eli Lilly's Elanco animal health division purchasing Johnson & Johnson's Janssen Animal Health business.

Johnson & Johnson

U.S. / Large-Cap Biopharma (>=$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Eli Lilly and Co.

U.S. / Large-Cap Biopharma (>=$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced